Moderna Update:
Biotech company Moderna will apply Monday for an emergency use authorization from the U.S. Food and Drug Administration after receiving more good news about the safety and effectiveness of its candidate COVID-19 vaccine. Moderna's latest findings, according to a company press release, showed that of 196 people in the clinical trial who caught COVID-19, 185 of them had received the placebo, while only 11 received the active vaccine. That works out to an effectiveness rate above 94%. Of the 30 participants who suffered severe disease, all were in the placebo group, suggesting that the vaccine prevents both mild and serious disease. One placebo recipient died.
The Cambridge, Massachusetts-based company, said it anticipates the FDA's advisory committee will discuss mRNA-1273 on Dec. 17, a week after it meets to discuss Pfizer's vaccine, with authorization expected to come a few days after each meeting.
Biotech company Moderna will apply Monday for an emergency use authorization from the U.S. Food and Drug Administration after receiving more good news about the safety and effectiveness of its candidate COVID-19 vaccine. Moderna's latest findings, according to a company press release, showed that of 196 people in the clinical trial who caught COVID-19, 185 of them had received the placebo, while only 11 received the active vaccine. That works out to an effectiveness rate above 94%. Of the 30 participants who suffered severe disease, all were in the placebo group, suggesting that the vaccine prevents both mild and serious disease. One placebo recipient died.
The Cambridge, Massachusetts-based company, said it anticipates the FDA's advisory committee will discuss mRNA-1273 on Dec. 17, a week after it meets to discuss Pfizer's vaccine, with authorization expected to come a few days after each meeting.
Moderna becomes second company to request emergency FDA authorization for COVID-19 vaccine candidate
Moderna will be the second coronavirus vaccine maker to request authorization from the government after similarly positive trial results for Pfizer.
news.yahoo.com